Search results
Results from the WOW.Com Content Network
Medscape is a website providing access to medical information for clinicians and medical scientists; the organization also provides continuing education for physicians and other health professionals. It references medical journal articles, Continuing Medical Education (CME), a version of the National Library of Medicine 's MEDLINE database ...
In December, the FDA authorized the use of a rapid testing kit developed by Brisbane, Australia-based Ellume Health. The test is available for purchase without a prescription for about $30 and can give results in about 20 minutes. [62] [63] The FDA approved the test for people with and without COVID symptoms. [63]
They publish WebMD the Magazine, a patient-directed publication distributed bimonthly free of charge to 85 percent of physician waiting rooms. [13] Medscape is a professional portal for physicians and has training materials, a drug database, and clinical information on 30 medical specialty areas and more than 30 physician discussion boards. [ 14 ]
The U.S. Federal Drug Administration (FDA) approved testing pooled samples to help speed up the coronavirus detection process and conserve supplies. The FDA reissued an existing emergency use ...
Here's how, plus more FDA-approved options. You can sign up for your four free at-home COVID-19 rapid tests starting today. Here's how, plus more FDA-approved options.
Co-Diagnostics Inc (NASDAQ: CODX) shares were rallying Tuesday following an update from the company regarding its COVID-19 test. The molecular diagnostic company said a revised FDA policy on COVID ...
No description. Template parameters [Edit template data] Parameter Description Type Status state state no description Unknown optional The above documentation is transcluded from Template:COVID-19 testing by country/doc. (edit | history) Editors can experiment in this template's sandbox (edit | diff) and testcases (create) pages. Add categories to the /doc subpage. Subpages of this template.
It also received EUA for its m2000-based laboratory nucleic acid test for COVID-19. [2] In April 2020, Abbott received EUA for its ARCHITECT IgG laboratory antibody test for COVID-19. [3] Also in April, Abbott's ID NOW test was reported to have sensitivity of 85.2%. [4] A later study found sensitivity of only 52%, inducing the FDA to issue an ...